Abstract
Understanding the relationship between genetic variations and brain abnormalities is crucial for uncovering the cross-scale pathophysiological mechanisms underlying schizophrenia. This cross-sectional study identifies brain structural correlates of individual variation in gene expression in schizophrenia and its clinical implication. RNA-sequencing data from blood samples, magnetic resonance imaging scans and clinical assessments were collected from 43 patients with schizophrenia, together with data from 60 healthy controls. Using RNA-sequencing data we show alterations in both gene-level and isoform-level expression between patients with schizophrenia and healthy controls (1,836 genes and 1,104 isoforms, false-discover-rate-adjusted P < 0.05). We also show differential gene expression to be associated with schizophrenia-related genomic variations (based on genome-wide association study data on 76,755 patients and 243,649 controls; regression coefficient (β) = 0.211, P = 0.001) and differential brain gene expression (P < 0.001, hypergeometric test). Multivariate correlation analysis combining gene expression and brain imaging shows that transcriptional levels of differentially expressed genes significantly correlate with gray matter volume in the frontal and temporal regions of cognitive brain networks in patients with schizophrenia (P < 0.001, permutation test). Findings show a significant association between gene expression, gray matter volume and cognitive performance in patients (P = 0.031, permutation test). Our results suggest that genomic variants in individuals with schizophrenia are associated with alterations in the transcriptome, which plays a role in individual variations in macroscale brain structure and cognition, contributing to building a comprehensive, multi-omics marker for the assessment of schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$79.00 per year
only $6.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The tabulated brain volume data and genetic summary statistics are publicly available at https://github.com/CAIMI-WEIGroup/NMH2024_SCZ_DEG_MRI. The raw MRI data are available from the corresponding author upon reasonable request. The raw RNA-seq data of 103 participants are available from the corresponding author upon reasonable request after having all relevant approvals from China’s Ministry of Science and Technology related to the export of genetic information and materials relevant to this work. Data from blood-derived DEGs reported in meta-analyses of microarray data in SCZ were downloaded from ref. 20 (2,145 genes) and ref. 21 (247 genes); gene expression data from brain samples of those with SCZ were downloaded from ref. 6; data from transcriptome-wide association studies in SCZ were downloaded from http://gusevlab.org/projects/chromatinTWAS/; data from PGC (wave 3) were downloaded from ref. 2; data from GWAS summary statistics on SCZ, BD, ADHD, ASD and MDD were downloaded from https://pgc.unc.edu/; data from GWAS summary statistics from insomnia were downloaded from https://cncr.nl/research/summary_statistics/; data of whole-brain gene expression profiles from the Allen Human Brain Atlas were downloaded from https://human.brain-map.org/; and data from GTEx were downloaded from https://gtexportal.org.
Code availability
The code supporting the findings of this study is available at https://github.com/CAIMI-WEIGroup/NMH2024_SCZ_DEG_MRI.
References
Owen, M. J., Sawa, A. & Mortensen, P. B. Schizophrenia. Lancet 388, 86–97 (2016).
Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502–508 (2022).
Pocklington, A. J. et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 86, 1203–1214 (2015).
Singh, T. et al. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat. Genet. 49, 1167–1173 (2017).
Wainberg, M. et al. Opportunities and challenges for transcriptome-wide association studies. Nat. Genet. 51, 592–599 (2019).
Gandal, M. J. et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science https://doi.org/10.1126/science.aat8127 (2018).
Perez, J. M. et al. Hippocampal subfield transcriptome analysis in schizophrenia psychosis. Mol. Psychiatry 26, 2577–2589 (2021).
van den Heuvel, M. P., Scholtens, L. H. & Kahn, R. S. Multiscale neuroscience of psychiatric disorders. Biol. Psychiatry 86, 512–522 (2019).
Neilson, E. et al. Impact of polygenic risk for schizophrenia on cortical structure in UK Biobank. Biol. Psychiatry 86, 536–544 (2019).
Wei, Y. et al. Associated genetics and connectomic circuitry in schizophrenia and bipolar disorder. Biol. Psychiatry 94, 174–183 (2023).
Cao, H., Zhou, H. & Cannon, T. D. Functional connectome-wide associations of schizophrenia polygenic risk. Mol. Psychiatry 26, 2553–2561 (2021).
Ji, Y. et al. Genes associated with gray matter volume alterations in schizophrenia. NeuroImage 225, 117526 (2021).
Ma, L. et al. Multi-scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients. J. Mol. Cell. Biol. 11, 678–687 (2019).
Romme, I. A. C., de Reus, M. A., Ophoff, R. A., Kahn, R. S. & van den Heuvel, M. P. Connectome disconnectivity and cortical gene expression in patients with schizophrenia. Biol. Psychiatry 81, 495–502 (2017).
Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391–399 (2012).
Wei, Y. et al. Statistical testing in transcriptomic-neuroimaging studies: a how-to and evaluation of methods assessing spatial and gene specificity. Hum. Brain Mapp. 43, 885–901 (2022).
Qi, T. et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat. Commun. 9, 2282 (2018).
Sullivan, P. F., Fan, C. & Perou, C. M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Gen. B 141B, 261–268 (2006).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Hess, J. L. et al. Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia. Schizophr. Res. 176, 114–124 (2016).
Bergon, A. et al. CX3CR1 is dysregulated in blood and brain from schizophrenia patients. Schizophr. Res. 168, 434–443 (2015).
Gusev, A. et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat. Genet. 50, 538–548 (2018).
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 49, D325–D334 (2021).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
Lam, M. et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet. 51, 1670–1678 (2019).
Merikangas, A. K. et al. What genes are differentially expressed in individuals with schizophrenia? A systematic review. Mol. Psychiatry 27, 1373–1383 (2022).
Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 53, 817–829 (2021).
Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 73, 1705–1715 (2018).
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
Jansen, P. R. et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat. Genet. 51, 394–403 (2019).
Gandal, M. J. et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359, 693–697 (2018).
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
Yeo, B. T. T. et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 106, 1125–1165 (2011).
Wei, Y. et al. Genetic mapping and evolutionary analysis of human-expanded cognitive networks. Nat. Commun. 10, 4839 (2019).
Burt, J. B., Helmer, M., Shinn, M., Anticevic, A. & Murray, J. D. Generative modeling of brain maps with spatial autocorrelation. NeuroImage 220, 117038 (2020).
Fulcher, B. D., Arnatkeviciute, A. & Fornito, A. Overcoming false-positive gene-category enrichment in the analysis of spatially resolved transcriptomic brain atlas data. Nat. Commun. 12, 2669 (2021).
Guan, F. et al. Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction. Mol. Psychiatry 27, 113–126 (2022).
Zhao, S.-W. et al. Shaping the trans-scale properties of schizophrenia via cerebral alterations on magnetic resonance imaging and single-nucleotide polymorphisms of coding and non-coding regions. Front. Hum. Neurosci. 15, 720239 (2021).
Rimol, L. M. et al. Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol. Psychiatry 71, 552–560 (2012).
Gebicke-Haerter, P. J. et al. Differential gene regulation in the anterior cingulate cortex and superior temporal cortex in schizophrenia: a molecular network approach. Schizophr. Res. https://doi.org/10.1016/j.schres.2021.04.014 (2021).
Fornito, A., Arnatkevičiūtė, A. & Fulcher, B. D. Bridging the gap between connectome and transcriptome. Trends Cogn. Sci. 23, 34–50 (2019).
Walker, R. L. et al. Genetic control of expression and splicing in developing human brain informs disease mechanisms. Cell 181, 745 (2020).
Di Biase, M. A. et al. Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia. Mol. Psychiatry 27, 2052–2060 (2022).
Kaufmann, T. et al. Disintegration of sensorimotor brain networks in schizophrenia. Schizophr. Bull. 41, 1326–1335 (2015).
Berman, R. A. et al. Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia. Brain 139, 276–291 (2016).
Arnatkeviciute, A. et al. Genetic influences on hub connectivity of the human connectome. Nat. Commun. 12, 4237 (2021).
Cui, L.-B. et al. Connectome-based patterns of first-episode medication-naïve patients with schizophrenia. Schizophr. Bull. 45, 1291–1299 (2019).
Kelly, S. et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol. Psychiatry 23, 1261–1269 (2018).
van den Heuvel, M. P. et al. Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry 70, 783–792 (2013).
Khalil, M., Hollander, P., Raucher-Chéné, D., Lepage, M. & Lavigne, K. M. Structural brain correlates of cognitive function in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 132, 37–49 (2022).
Smeland, O. B. et al. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol. Psychiatry 25, 844–853 (2020).
Legge, S. E. et al. Associations between schizophrenia polygenic liability, symptom dimensions, and cognitive ability in schizophrenia. JAMA Psychiatry 78, 1143–1151 (2021).
Ukkola-Vuoti, L. et al. Gene expression changes related to immune processes associate with cognitive endophenotypes of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 88, 159–167 (2019).
van der Meer, D. et al. Boosting schizophrenia genetics by utilizing genetic overlap with brain morphology. Biol. Psychiatry 92, 291–298 (2022).
Cheng, W. et al. Genetic association between schizophrenia and cortical brain surface area and thickness. JAMA Psychiatry 78, 1020–1030 (2021).
GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
Piwecka, M., Rajewsky, N. & Rybak-Wolf, A. Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat. Rev. Neurol. 19, 346–362 (2023).
Hafizi, S. et al. TSPO expression and brain structure in the psychosis spectrum. Brain Behav. Immun. 74, 79–85 (2018).
Cui, P. et al. Identification of human circadian genes based on time course gene expression profiles by using a deep learning method. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2274–2283 (2018).
Davis, R., Murgia, C., Dordevic, A. L., Bonham, M. P. & Huggins, C. E. Diurnal variation in gene expression of human peripheral blood mononuclear cells after eating a standard meal compared with a high protein meal: a cross-over study. Clin. Nutr. 40, 4349–4359 (2021).
Oraki Kohshour, M., Papiol, S., Delalle, I., Rossner, M. J. & Schulze, T. G. Extracellular vesicle approach to major psychiatric disorders. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1279–1293 (2023).
Bigos, K. L. & Weinberger, D. R. Imaging genetics—days of future past. NeuroImage 53, 804–809 (2010).
Ibrahim, E. C. et al. Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients. NPJ Schizophr. 3, 25 (2017).
Chegraoui, H. et al. Integrating multiomics and prior knowledge: a study of the Graphnet penalty impact. Bioinformatics 39, btad454 (2023).
Kalin, N. H. Molecules and circuits implicated in schizophrenia provide leads for novel treatments. Am. J. Psychiatry 177, 1099–1102 (2020).
Wang, M. et al. Transcriptomic and neuroimaging data integration enhances machine learning classification of schizophrenia. Psychoradiology 4, kkae005 (2024).
Kebets, V. et al. Somatosensory-motor dysconnectivity spans multiple transdiagnostic dimensions of psychopathology. Biol. Psychiatry 86, 779–791 (2019).
Zoller, D. et al. Disentangling resting-state BOLD variability and PCC functional connectivity in 22q11.2 deletion syndrome. NeuroImage 149, 85–97 (2017).
Zoller, D. et al. Psychotic symptoms influence the development of anterior cingulate BOLD variability in 22q11.2 deletion syndrome. Schizophr. Res. 193, 319–328 (2018).
Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276 (1987).
Gong, Y.-X. Wechsler Adult Intelligence Scale Revised in China version 48-53 (Hunan Medical College, 1982).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).
Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290–295 (2015).
Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084–2092 (2019).
Cammoun, L. et al. Mapping the human connectome at multiple scales with diffusion spectrum MRI. J. Neurosci. Methods 203, 386–397 (2012).
Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968–980 (2006).
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. NeuroImage 62, 782–790 (2012).
de Lange, S. C., Helwegen, K. & van den Heuvel, M. P. Structural and functional connectivity reconstruction with CATO—A Connectivity Analysis TOolbox. NeuroImage 273, 120108 (2023).
Krishnan, A., Williams, L. J., McIntosh, A. R. & Abdi, H. Partial least squares (PLS) methods for neuroimaging: a tutorial and review. NeuroImage 56, 455–475 (2011).
McIntosh, A. R. & Mišić, B. Multivariate statistical analyses for neuroimaging data. Annu. Rev. Psychol. 64, 499–525 (2013).
Zöller, D. et al. Large-scale brain network dynamics provide a measure of psychosis and anxiety in 22q11.2 deletion syndrome. Biol. Psychiatry Cogn Neurosci. Neuroimaging 4, 881–892 (2019).
Shen, E. H., Overly, C. C. & Jones, A. R. The Allen Human Brain Atlas: comprehensive gene expression mapping of the human brain. Trends Neurosci. 35, 711–714 (2012).
Acknowledgements
This study received funding from the National Natural Science Foundation of China (grant number 82271949 to L.-B.C., grant number 82202264 to Y.W. and grant number 81974215 to H.-N.W.), China Postdoctoral Science Foundation (grant number 2019TQ0130 to L.-B.C.), Beijing Municipal Natural Science Foundation (grant number 7232341 to Y.W.), Key Research and Development Program of Shaanxi Province (grant number 2023-YBSF-444 to D.W.), Shaanxi Natural Science Foundation (grant number 2022JQ-908 to W.-J.W.), European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement ERC-COG number 101001062 to M.P.v.d.H.) and the Netherlands Organization for Scientific Research (VIDI grant number 452-16-015 to M.P.v.d.H., ALW open grant number ALWOP.179 to M.P.v.d.H. and Gravitation project BRAINSCAPES: A Road map from Neurogenetics to Neurobiology, grant number 024.004.012 to M.P.v.d.H.). Analyses were supported by the High-Performance Computing Platform of BUPT. We thank X.-J. Wang and F. Cao for their continued scientific support.
Author information
Authors and Affiliations
Contributions
L.-B.C. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. L.-B.C., S.-W.Z., Y.-H.Z., K.C., Y.-F.F., M.W., J.-W.F., Y.-W.G., X.-F.L., X.-S.L., W.-J.W., D.W., H.-N.W., Y.W. and M.P.v.d.H. were responsible for acquisition, analysis or interpretation of data. L.-B.C., T.Q. and Y.W. were responsible for drafting the article. All authors provided critical revision of the article for important intellectual content. L.-B.C., S.-W.Z. and Y.W. were responsible for statistical analysis. L.-B.C., D.W., H.-N.W., M.P.v.d.H. and Y.W. obtained funding. Y.L., H.Y. and M.P.v.d.H. provided supervision.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Mental Health thanks El Cherif Ibrahim and the other, anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Methods, Results, Figs. 1–6 and references.
44220_2024_306_MOESM3_ESM.xlsx
Supplementary Table 1 Demographic and clinical data of participants. Supplementary Table 2 DEGs in blood samples from people with SCZ. Supplementary Table 3 Overlaps between DEGs and risk genes reported in TWAS on SCZ. Supplementary Table 4 Gene-set analysis for gene sets involved in GO cellular components. Supplementary Table 5 Gene-set analysis for GWAS-Catalog-reported gene sets. Supplementary Table 6 Differentially expressed transcripts in blood samples from those with SCZ. Supplementary Table 7 Overlaps between DEGs and risk genes derived from GWAS using different SNP-to-gene mapping approaches. Supplementary Table 8 Overlaps between upregulated/downregulated DEGs and risk genes derived from GWAS. Supplementary Table 9 The most important genes contributing to the transcription–GMV association in SCZ revealed by LASSO. Supplementary Table 10 Scanning parameters.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cui, LB., Zhao, SW., Zhang, YH. et al. Associated transcriptional, brain and clinical variations in schizophrenia. Nat. Mental Health (2024). https://doi.org/10.1038/s44220-024-00306-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s44220-024-00306-1